NCT02118324View on ClinicalTrials.gov

Exergaming Intervention in ALL Patients

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

January 31, 2016

Conditions
Acute Lymphoblastic Leukemia
Interventions
BEHAVIORAL

Exergaming Program

Participants will exercise through exergaming play.

Trial Locations (1)

55454

University of Minnesota Amplatz Children's Hospital, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02118324 - Exergaming Intervention in ALL Patients | Biotech Hunter | Biotech Hunter